The authors present the case of a woman with bipolar disorder who
developed reticulocytosis after two trials of carbamazepine. They urge that
blood indices be carefully monitored whenever carbamazepine is used.
Subscribe Now/Learn More
Purchase Online access to this article for 24 hours
PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books,
journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists
and mental health professionals with key resources for diagnosis, treatment, research,
and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org
or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).